These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 15246845)
21. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles. Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945 [TBL] [Abstract][Full Text] [Related]
22. Compounds with the dioxopyrimidine cycle inhibit cholinesterases from different groups of animals. Anikienko KA; Bychikhin EA; Reznik VS; Akamsin D; Galyametdinova IV Chem Biol Interact; 2008 Sep; 175(1-3):286-92. PubMed ID: 18585370 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of two different cholinesterases by tacrine. Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Darvesh S; McDonald RS; Penwell A; Conrad S; Darvesh KV; Mataija D; Gomez G; Caines A; Walsh R; Martin E Bioorg Med Chem; 2005 Jan; 13(1):211-22. PubMed ID: 15582466 [TBL] [Abstract][Full Text] [Related]
25. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer? Macdonald IR; Rockwood K; Martin E; Darvesh S J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642 [TBL] [Abstract][Full Text] [Related]
26. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Wszelaki N; Kuciun A; Kiss AK Acta Pharm; 2010 Mar; 60(1):119-28. PubMed ID: 20228046 [TBL] [Abstract][Full Text] [Related]
27. Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: effects of sex hormone withdrawal. Alves-Amaral G; Pires-Oliveira M; Andrade-Lopes AL; Chiavegatti T; Godinho RO Chem Biol Interact; 2010 Jun; 186(1):9-15. PubMed ID: 20399201 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of huperzine B on cholinesterase activity in mice. Liu J; Zhang HY; Wang LM; Tang XC Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161 [TBL] [Abstract][Full Text] [Related]
29. Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition. Mohr F; Zimmermann M; Klein J Neuropharmacology; 2013 Apr; 67():37-45. PubMed ID: 23147415 [TBL] [Abstract][Full Text] [Related]
30. Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults. Morasch KC; Aaron CL; Moon JE; Gordon RK Physiol Behav; 2015 Jan; 138():165-72. PubMed ID: 25455867 [TBL] [Abstract][Full Text] [Related]
32. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231 [TBL] [Abstract][Full Text] [Related]
33. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Lane RM; Potkin SG; Enz A Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515 [TBL] [Abstract][Full Text] [Related]
34. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers. Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732 [TBL] [Abstract][Full Text] [Related]
35. Inhibition and recovery of maternal and fetal cholinesterase enzymes following a single oral dose of chlorpyrifos in rats. Ashry KM; Abu-Qare AW; Saleem FR; Hussein YA; Hamza SM; Kishk AM; Abou-Donia MB Arch Toxicol; 2002 Feb; 76(1):30-9. PubMed ID: 11875622 [TBL] [Abstract][Full Text] [Related]
36. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Rakonczay Z Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624 [TBL] [Abstract][Full Text] [Related]
37. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032 [TBL] [Abstract][Full Text] [Related]
38. Cholinesterase inhibitors: new roles and therapeutic alternatives. Giacobini E Pharmacol Res; 2004 Oct; 50(4):433-40. PubMed ID: 15304240 [TBL] [Abstract][Full Text] [Related]
39. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Shih TM; Kan RK; McDonough JH Chem Biol Interact; 2005 Dec; 157-158():293-303. PubMed ID: 16256093 [TBL] [Abstract][Full Text] [Related]
40. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier. Prinz M; Parlar S; Bayraktar G; Alptüzün V; Erciyas E; Fallarero A; Karlsson D; Vuorela P; Burek M; Förster C; Turunc E; Armagan G; Yalcin A; Schiller C; Leuner K; Krug M; Sotriffer CA; Holzgrabe U Eur J Pharm Sci; 2013 Jul; 49(4):603-13. PubMed ID: 23643737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]